Tau Medical is a pioneering medtech venture dedicated to
advancing innovative, catheter-based therapies for structural and
electrophysiological heart diseases—conditions that impact millions worldwide.

Backed by over $60 million in venture capital and government
funding, and supported by a growing team of more than 50
cardiologists, engineers, and clinical experts, Tau is setting a
new standard in minimally invasive cardiac care. Our proprietary
technologies are designed to address serious unmet clinical needs
and reshape the future of heart valve therapy.